Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272What this trial is testingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more 23andMe, Inc. 141
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)UnknownNCT01584115What this trial is testingClinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)Who this might be right forCancer.Melanoma.Ovarian Cancer.+1 more Instituto de Investigação em Imunologia 15
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT02307500What this trial is testingRegorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyWho this might be right forPancreas CancerOvarian CancerMelanoma+4 more Istituto Clinico Humanitas 82
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT01178411What this trial is testingAn Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) ProtocolsWho this might be right forAdvanced Solid Tumors ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Not applicableStudy completedNCT05697198What this trial is testingPRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineWho this might be right forLung CancerOvarian CancerUterine Cancer+10 more Labcorp Corporation of America Holdings, Inc 1,429
Not applicableLooking for participantsNCT03050268What this trial is testingFamilial Investigations of Childhood Cancer PredispositionWho this might be right forAcute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more St. Jude Children's Research Hospital 1,500
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT06613230What this trial is testingImproved Early Diagnosis in Female Pelvic Cancer With OC DetectWho this might be right forOvarian CancerEndometrial CancerBreast Cancer+3 more Region Skane 490